Cargando…

Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance

BACKGROUND: There is strong evidence that portal vein tumor thrombosis (PVTT) is associated with poor survival in patients with hepatocellular carcinoma (HCC). However, data regarding the clinical significance of hepatic vein tumor thrombosis (HVTT) is rare, particularly in Western patients. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mähringer‐Kunz, Aline, Meyer, Franziska I., Hahn, Felix, Müller, Lukas, Düber, Christoph, Pinto Dos Santos, Daniel, Galle, Peter R., Weinmann, Arndt, Kloeckner, Roman, Schotten, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259264/ https://www.ncbi.nlm.nih.gov/pubmed/34077613 http://dx.doi.org/10.1002/ueg2.12098

Ejemplares similares

Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Müller, Lukas, et al.
Publicado: (2021)

The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study
por: Mähringer-Kunz, Aline, et al.
Publicado: (2021)

Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study
por: Stoehr, Fabian, et al.
Publicado: (2022)

High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Distant Metastases in Patients with Intrahepatic Cholangiocarcinoma: Does Location Matter? A Retrospective Analysis of 370 Patients
por: Hahn, Felix, et al.
Publicado: (2020)

Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging
por: Hahn, Felix, et al.
Publicado: (2020)

Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8(th) edition of the UICC/AJCC Cancer staging system
por: Hahn, Felix, et al.
Publicado: (2020)

Risk Stratification in Advanced Biliary Tract Cancer: Validation of the A.L.A.N. Score
por: Müller, Lukas, et al.
Publicado: (2020)

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide
por: Müller, Lukas, et al.
Publicado: (2021)

Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function
por: Müller, Lukas, et al.
Publicado: (2021)

Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?
por: Müller, Lukas, et al.
Publicado: (2021)

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma
por: Mähringer-Kunz, Aline, et al.
Publicado: (2018)

Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC
por: Müller, Lukas, et al.
Publicado: (2022)

Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index
por: Müller, Lukas, et al.
Publicado: (2021)

Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment
por: Müller, Lukas, et al.
Publicado: (2021)

Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?
por: Müller, Lukas, et al.
Publicado: (2022)

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis
por: Chen, Jifan, et al.
Publicado: (2020)

Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates
por: Müller, Lukas, et al.
Publicado: (2023)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy
por: Müller, Lukas, et al.
Publicado: (2022)

Quantitative assessment of washout in hepatocellular carcinoma using MRI
por: Kloeckner, Roman, et al.
Publicado: (2016)

Clinical application of the contrast-enhancement boost technique in computed tomography angiography of the portal vein
por: Hou, Juan, et al.
Publicado: (2022)

Commercial AI solutions in detecting COVID-19 pneumonia in chest CT: not yet ready for clinical implementation?
por: Jungmann, Florian, et al.
Publicado: (2021)

Online teaching in radiology as a pilot model for modernizing medical education: results of an international study in cooperation with the ESR
por: Stoehr, Fabian, et al.
Publicado: (2021)

The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapy
por: Müller, Lukas, et al.
Publicado: (2022)

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome
por: Heinrich, Sophia, et al.
Publicado: (2022)

Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR)
por: Obmann, V. C., et al.
Publicado: (2020)

Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey
por: Zecher, Britta Franziska, et al.
Publicado: (2021)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

New concepts in the treatment of hepatocellular carcinoma
por: Sidali, Sabrina, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

Calcification of the visceral aorta and celiac trunk is associated with renal and allograft outcomes after deceased donor liver transplantation
por: Siepmann, Robert, et al.
Publicado: (2022)

Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma
por: Li, Xiaomi, et al.
Publicado: (2023)

Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma
por: He, Guangming, et al.
Publicado: (2023)

Multi-organ Radiomics-Based Prediction of Future Remnant Liver Hypertrophy Following Portal Vein Embolization
por: Gerwing, Mirjam, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review
por: Norero, Blanca, et al.
Publicado: (2023)

DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
por: Zheng, Jing, et al.
Publicado: (2023)

The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion
por: Liu, Jianwei, et al.
Publicado: (2023)

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
por: Lima, Henrique A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dscubqacurursmprq46oigvn8o